Nicole M Parrish

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings
    Nicole M Parrish
    Johns Hopkins Medical Institutions, Baltimore, Maryland, Baltimore, Maryland, USA
    J Clin Microbiol 49:772-6. 2011
  2. pmc Activity of DSA against anaerobically adapted Mycobacterium bovis BCG in vitro
    Nicole M Parrish
    Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Tuberculosis (Edinb) 89:325-7. 2009
  3. pmc Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis
    Nicole Parrish
    Department of Pathology, Division of Medical Microbiology, Johns Hopkins University, Baltimore, MD 21287, USA
    J Clin Microbiol 45:3915-20. 2007
  4. doi request reprint Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis
    Nicole Parrish
    The Johns Hopkins Medical Institutions, Johns Hopkins University, 600 North Wolfe Street, Meyer B1 193, Baltimore, MD 21287, USA
    Future Microbiol 3:405-13. 2008
  5. doi request reprint Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems
    Nicole Parrish
    The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Diagn Microbiol Infect Dis 63:342-5. 2009
  6. ncbi request reprint Effect of n-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Antimicrob Chemother 54:722-9. 2004
  7. pmc Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens
    David W Dowdy
    Johns Hopkins Bloomberg School of Public Health Johns Hopkins Hospital Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    J Clin Microbiol 41:948-53. 2003
  8. pmc Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics
    Nicole Parrish
    Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Clin Microbiol 49:2056-8. 2011
  9. pmc Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Med Res 2:107-14. 2004
  10. doi request reprint Absence of mycobacterium avium subsp. paratuberculosis in Crohn's patients
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Inflamm Bowel Dis 15:558-65. 2009

Collaborators

  • Karen C Carroll
  • Susan Dorman
  • Stefan Riedel
  • Kim Dionne
  • Victor Flauta
  • Cindy Hendry
  • Annie Hedgepeth
  • David W Dowdy
  • Gerard Osterhout
  • Melissa Sander
  • Michael Grayson
  • Sam Cohen
  • MYRON SASSER
  • Brandon Ellis
  • Amy Sweeney
  • Christopher Beyrer
  • Amelia Maters

Detail Information

Publications13

  1. pmc Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings
    Nicole M Parrish
    Johns Hopkins Medical Institutions, Baltimore, Maryland, Baltimore, Maryland, USA
    J Clin Microbiol 49:772-6. 2011
    ..Finally, gamma interferon release assays are preferred to the tuberculin skin test for screening certain at-risk populations, and new CDC guidelines are available that assist clinicians in their use...
  2. pmc Activity of DSA against anaerobically adapted Mycobacterium bovis BCG in vitro
    Nicole M Parrish
    Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Tuberculosis (Edinb) 89:325-7. 2009
    ..Conclusive identification of the DSA-specific target(s) will permit a better understanding of the unique mechanism of action of this class of compounds against both aerobically growing and anaerobically adapted bacilli in vitro...
  3. pmc Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis
    Nicole Parrish
    Department of Pathology, Division of Medical Microbiology, Johns Hopkins University, Baltimore, MD 21287, USA
    J Clin Microbiol 45:3915-20. 2007
    ..tuberculosis and offers the potential of providing susceptibility testing results within hours, rather than days or weeks, for clinical M. tuberculosis isolates...
  4. doi request reprint Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis
    Nicole Parrish
    The Johns Hopkins Medical Institutions, Johns Hopkins University, 600 North Wolfe Street, Meyer B1 193, Baltimore, MD 21287, USA
    Future Microbiol 3:405-13. 2008
    ..Such an approach is essential for the future of TB control and stemming the tide of MDR-TB and XDR-TB...
  5. doi request reprint Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems
    Nicole Parrish
    The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Diagn Microbiol Infect Dis 63:342-5. 2009
    ..The MGIT 960 demonstrated shorter time to detection (13.5 versus 25.2 days) and greater sensitivity (100% versus 66.6%) for recovery of the Mycobacterium tuberculosis complex than the BacT/ALERT MB system...
  6. ncbi request reprint Effect of n-octanesulphonylacetamide (OSA) on ATP and protein expression in Mycobacterium bovis BCG
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Antimicrob Chemother 54:722-9. 2004
    ..To determine the effect on BCG of n-octanesulphonylacetamide (OSA), a novel compound of the class beta-sulphonylcarboxamides, which has potent in vitro activity against pathogenic mycobacteria...
  7. pmc Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens
    David W Dowdy
    Johns Hopkins Bloomberg School of Public Health Johns Hopkins Hospital Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    J Clin Microbiol 41:948-53. 2003
    ....
  8. pmc Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics
    Nicole Parrish
    Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Clin Microbiol 49:2056-8. 2011
    ..Susceptibility testing is not routinely performed, and single-drug therapy is used for the treatment of most infections. Here, we report an infection caused by a drug-resistant M. marinum strain in an otherwise healthy patient...
  9. pmc Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Med Res 2:107-14. 2004
    ..We sought to test growth rates and susceptibilities of various strains of MAP in two available growth media...
  10. doi request reprint Absence of mycobacterium avium subsp. paratuberculosis in Crohn's patients
    Nicole M Parrish
    Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Inflamm Bowel Dis 15:558-65. 2009
    ..In addition, each blood sample was analyzed for polymorphisms in the NOD2/CARD15 gene previously associated with CD...
  11. doi request reprint Use of the "RAM" susceptibility testing method for rapid detection of clarithromycin resistance in the Mycobacterium avium complex
    Victor Flauta
    Division of Medical Microbiology, Department of Pathology, Johns Hopkins University, Baltimore, MD 21287, USA
    Diagn Microbiol Infect Dis 67:47-51. 2010
    ....
  12. pmc Evaluation of a rapid fluorescent staining method for detection of mycobacteria in clinical specimens
    Cindy Hendry
    The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Clin Microbiol 47:1206-8. 2009
    ..These results suggest that the rapid stain may be more cost-effective and efficient for use in clinical laboratories...
  13. pmc Methods for reducing bacterial contamination in the BacT/Alert mycobacterial culture detection system
    Kim Dionne
    Division of Medical Microbiology, Johns Hopkins University, Meyer B1 193, 600 N Wolfe Street, Baltimore, MD 21287, USA
    J Clin Microbiol 43:2523-5. 2005
    ..0 ml, of mycobacterial antibiotic supplement were evaluated. Contamination rates were 14% and 6% for the standard and the doubled concentrations, respectively. This difference was statistically significant (P < 0.005)...